The paper provides information on the prices paid by 20 middle-income countries for adult and paediatric formulations of antiretroviral (ARV) drugs recommended by the World Health Organization (WHO). It links this information with an analysis of the intellectual property situation of the selected ARV medicines ...

How do intellectual property rights affect access to HIV medicines and other health technologies? This document provides a review of key issues related to intellectual property policies and their potential impact on access to HIV and other medicines. It is intended as an introduction to the ...

This paper forms part of Phase 2 of a project undertaken by the World Health Organization and supported by the European Commission on improving access to medical products in developing countries through building capacity for local production and related technology transfer. Phase 1 of the project ...